TP Therapeutics, Inc. (TP) is a clinical-stage structure-based drug design company founded in October 2013 by Dr. J. Jean Cui, the lead inventor of Pfizer's oncology drug crizotinib. TP Team is focusing on the design and development of novel chemical identities for established oncogene drivers with high incidence of secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/23/17 | $45,000,000 | Series C |
Cormorant Asset Management Lilly Asia Ventures  OrbiMed Advisors SR One SV Tech Ventures | undisclosed |
